Developmental Funds

发展基金-项目摘要 发展基金在推进联合会的战略目标方面发挥着几个关键作用。几 在项目期间收到征聘资金的优秀调查员将不会 西雅图没有额外的支持，是通过提供CCSG新的调查基金。的 CCSG试点项目资金的可用性为癌症中心的研究人员提供了非常切实的好处 成员资格，并如本节后面所述，刺激了新的合作， 没有发生。而且，用于促进新的共享资源开发的资金为财团提供了资金， 成员获得技术和专门知识，否则这些技术和专门知识对个人来说是不可持续的。 实验室，甚至在许多情况下是机构基础。 在上一个赠款期间，发展资金支持了28个生产性财团的招聘。 战略增长领域的教职员工; 47个试点项目获得了26项赠款和 发表了32篇论文; 4篇开发生物信息学、组织库、肿瘤 模型和高吞吐量筛选。在这项申请中，要求为这些项目提供发展资金。 三种类型的高影响力活动以及两名特殊人群调查员。明确定义， 下文各小节介绍了长期以来联合会分配这些资金的程序。 发展基金的具体目标是： 1.在高战略领域，每年为最多9名新的联盟研究人员提供关键研究支持 对联盟的重要性，包括实体瘤转化研究，免疫治疗，健康差异 健康经济学和肥胖研究。 2.提供试点资金，每年激励5-7个最具创新性的联盟癌症研究项目。 奖励将针对战略增长领域（见具体目标1）以及鼓励新的途径 支持癌症诊断、治疗或预防方面最有前途的新项目， 重点放在刺激后续供资的可能性和在集水区的潜在影响。 3.开发新的生物医学信息学共享资源。这一资源得到了 高级领导人和我们的外部咨询委员会，并将整合所有联盟患者，标本， 临床试验和研究，以及相关的基因组学或其他测定数据，并有效地支持进一步的 实体瘤转化研究联盟的发展。 4.支持两名特殊人群调查员，他们将推进我们的战略目标， 在集水区开展研究，并加强少数民族参与联合会的研究。

Developmental Funds - Project Summary Developmental funds play several critical roles in furthering the Consortium's strategic objectives. Several outstanding investigators who received recruitment funds during the project period would not have come to Seattle without the extra support that was offered through the availability of CCSG new investigator funds. The availability of CCSG pilot project funding provides investigators a very tangible benefit of cancer center membership, and, as described later in this section, has stimulated new collaborations that would otherwise not have occurred. And, funds to catalyze new shared resource development have afforded Consortium members access to technologies and expertise that would otherwise not be sustainable on an individual laboratory or even in many cases an institutional basis. During the past grant period, developmental funds supported the recruitment of 28 productive Consortium faculty members in areas of strategic growth; 47 pilot projects resulting in the acquisition of 26 grants and the publication of 32 papers; and four developing shared resources for Bioinformatics, Tissue Bank, Tumor Models, and High Throughput Screening. In this application, developmental funds are requested for these three types of high impact activities as well as two Special Populations Staff Investigators. Clearly defined, longstanding Consortium processes for allocating these funds are described in each subsection below. The Specific Aims of Developmental Funds are to: 1. Provide critical research support for up to 9 new Consortium investigators per year in areas of high strategic importance to the Consortium, including solid tumor translational research, immunotherapy, health disparities research, health economics and obesity research. 2. Provide pilot funding to stimulate 5-7 of the most innovative Consortium cancer research projects annually. Awards will be targeted to areas of strategic growth (see specific aim 1) as well as to encourage new avenues of research to support the most promising new projects in cancer diagnosis, treatment or prevention, with emphasis placed on likelihood of stimulating follow-on funding and potential impact in the catchment area. 3. Develop a new Biomedical Informatics shared resource. This resource has been strongly endorsed by senior leaders and our External Advisory Board, and will integrate data on all Consortium patients, specimens, clinical trials and studies, and associated genomics or other assay data, and efficiently support the further development of Consortium solid tumor translational research. 4. Support two Special Populations Staff Investigators who will advance our strategic objective to increase research in the catchment area and enhance inclusion of minorities in Consortium research.